Briançon D, Charhon S, Edouard C, Meunier P J
Rev Rhum Mal Osteoartic. 1980 Dec;47(12):693-8.
A histomorphometric and dynamic study of non-decalcified transiliac biopsies was carried out in 51 cases of osteoporosis who had received double marking with tetracycline before and after two years treatment with association of sodium fluoride (50 mg/day) vitamin, D2 (8,000 IU/day) and calcium (1 g/day). The main effect of fluoride is an increase in the osteoblastic population, which is shown by an increase in the osteoid parameters. The osteoid volume is multiplied by 3,6, the osteoid surfaces by 2,4, and the index of osteoid thickness by 1,2. There exists a lesser increase in the reabsorption surfaces (X 1,2). There results a very significant increase in bony trabecular volume, the average value of which increase from 9,8 +/- 3,1% to 16,6 +/- 9.3% (X 1,8; p < 0.001). These results were found again both in apparently primary osteoporosis and in secondary osteoporosis. No significant depression was noted in the rate of calcification, but six patients developed a state of histological osteomalacia associated in 5 cases with an increased calcified volume. All these results are in good agreement with those of the world literature and indicate that fluoride is able in most cases (60%) to restore normal bones in osteoporosis with reduced risk of fracture.
对51例骨质疏松症患者进行了非脱钙经髂骨活检的组织形态计量学和动态研究,这些患者在接受氟化钠(50毫克/天)、维生素D2(8000国际单位/天)和钙(1克/天)联合治疗两年前后用四环素进行了双重标记。氟化物的主要作用是成骨细胞数量增加,这表现为类骨质参数增加。类骨质体积增加到3.6倍,类骨质表面积增加到2.4倍,类骨质厚度指数增加到1.2倍。重吸收表面的增加较小(1.2倍)。结果骨小梁体积非常显著增加,其平均值从9.8±3.1%增加到16.6±9.3%(1.8倍;p<0.001)。在原发性骨质疏松症和继发性骨质疏松症中均再次发现这些结果。钙化率未见明显降低,但6例患者出现组织学骨软化状态,其中5例伴有钙化体积增加。所有这些结果与世界文献的结果一致,表明氟化物在大多数情况下(60%)能够使骨质疏松症患者的骨骼恢复正常,降低骨折风险。